361 related articles for article (PubMed ID: 18523298)
1. Transient local depletion of Foxp3+ regulatory T cells during recovery from colitis via Fas/Fas ligand-induced death.
Reardon C; Wang A; McKay DM
J Immunol; 2008 Jun; 180(12):8316-26. PubMed ID: 18523298
[TBL] [Abstract][Full Text] [Related]
2. TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment.
Chen X; Wu X; Zhou Q; Howard OM; Netea MG; Oppenheim JJ
J Immunol; 2013 Feb; 190(3):1076-84. PubMed ID: 23277487
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the immuno-regulatory response to the tapeworm Hymenolepis diminuta in the non-permissive mouse host.
Persaud R; Wang A; Reardon C; McKay DM
Int J Parasitol; 2007 Mar; 37(3-4):393-403. PubMed ID: 17092505
[TBL] [Abstract][Full Text] [Related]
4. Activated CD8+ T-effector/memory cells eliminate CD4+ CD25+ Foxp3+ T-suppressor cells from tumors via FasL mediated apoptosis.
Kilinc MO; Rowswell-Turner RB; Gu T; Virtuoso LP; Egilmez NK
J Immunol; 2009 Dec; 183(12):7656-60. PubMed ID: 19923444
[TBL] [Abstract][Full Text] [Related]
5. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression.
Fantini MC; Rizzo A; Fina D; Caruso R; Sarra M; Stolfi C; Becker C; Macdonald TT; Pallone F; Neurath MF; Monteleone G
Gastroenterology; 2009 Apr; 136(4):1308-16, e1-3. PubMed ID: 19192480
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells.
Dominitzki S; Fantini MC; Neufert C; Nikolaev A; Galle PR; Scheller J; Monteleone G; Rose-John S; Neurath MF; Becker C
J Immunol; 2007 Aug; 179(4):2041-5. PubMed ID: 17675459
[TBL] [Abstract][Full Text] [Related]
7. Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice.
Lahl K; Mayer CT; Bopp T; Huehn J; Loddenkemper C; Eberl G; Wirnsberger G; Dornmair K; Geffers R; Schmitt E; Buer J; Sparwasser T
J Immunol; 2009 Nov; 183(9):5662-72. PubMed ID: 19812199
[TBL] [Abstract][Full Text] [Related]
8. CD4+FoxP3+ regulatory T cells from Gαi2-/- mice are functionally active in vitro, but do not prevent colitis.
Götlind YY; Raghavan S; Bland PW; Hörnquist EH
PLoS One; 2011; 6(9):e25073. PubMed ID: 21966415
[TBL] [Abstract][Full Text] [Related]
9. Gut Inflammation in Mice Triggers Proliferation and Function of Mucosal Foxp3+ Regulatory T Cells but Impairs Their Conversion from CD4+ T Cells.
Boschetti G; Kanjarawi R; Bardel E; Collardeau-Frachon S; Duclaux-Loras R; Moro-Sibilot L; Almeras T; Flourié B; Nancey S; Kaiserlian D
J Crohns Colitis; 2017 Jan; 11(1):105-117. PubMed ID: 27364948
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
Brode S; Raine T; Zaccone P; Cooke A
J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
[TBL] [Abstract][Full Text] [Related]
11. The role of Fas in the immune system biology of IL-2R alpha knockout mice: interplay among regulatory T cells, inflammation, hemopoiesis, and apoptosis.
Sharma R; Bagavant H; Jarjour WN; Sung SS; Ju ST
J Immunol; 2005 Aug; 175(3):1965-73. PubMed ID: 16034141
[TBL] [Abstract][Full Text] [Related]
12. Foxp3-mediated suppression of CD95L expression confers resistance to activation-induced cell death in regulatory T cells.
Weiss EM; Schmidt A; Vobis D; Garbi N; Lahl K; Mayer CT; Sparwasser T; Ludwig A; Suri-Payer E; Oberle N; Krammer PH
J Immunol; 2011 Aug; 187(4):1684-91. PubMed ID: 21746966
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3
Chen X; Berin MC; Gillespie VL; Sampson HA; Dunkin D
Front Immunol; 2021; 12():637630. PubMed ID: 33717186
[No Abstract] [Full Text] [Related]
14. Suppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis.
Liu H; Wang Y; Zeng Q; Zeng YQ; Liang CL; Qiu F; Nie H; Dai Z
Oncotarget; 2017 Apr; 8(15):24187-24195. PubMed ID: 28445940
[TBL] [Abstract][Full Text] [Related]
15. CD3+CD4+LAP+Foxp3-Regulatory Cells of the Colonic Lamina Propria Limit Disease Extension in Ulcerative Colitis.
Butera A; Sanchez M; Pronio A; Amendola A; De Nitto D; Di Carlo N; Lande R; Frasca L; Borrini F; Pica R; Boirivant M
Front Immunol; 2018; 9():2511. PubMed ID: 30425718
[No Abstract] [Full Text] [Related]
16. Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis.
Strauss L; Bergmann C; Whiteside TL
J Immunol; 2009 Feb; 182(3):1469-80. PubMed ID: 19155494
[TBL] [Abstract][Full Text] [Related]
17. Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation.
Boehm F; Martin M; Kesselring R; Schiechl G; Geissler EK; Schlitt HJ; Fichtner-Feigl S
BMC Gastroenterol; 2012 Jul; 12():97. PubMed ID: 22849659
[TBL] [Abstract][Full Text] [Related]
18. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
Bhaumik S; Mickael ME; Moran M; Spell M; Basu R
J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282
[TBL] [Abstract][Full Text] [Related]
19. Analysis of murine and human Treg subsets in inflammatory bowel disease.
Sun X; He S; Lv C; Sun X; Wang J; Zheng W; Wang D
Mol Med Rep; 2017 Sep; 16(3):2893-2898. PubMed ID: 28677759
[TBL] [Abstract][Full Text] [Related]
20. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
Elinav E; Waks T; Eshhar Z
Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
